We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VWS:OMXCOPVestas Wind Systems A/S Analysis

Data as of 2026-03-10 - not real-time

DKK 158.30

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Vestas (VWS.CO) is trading at DKK 158.3, essentially flat on its 20‑day SMA (158.3) but still below the 50‑day SMA (172.7) and above the 200‑day SMA (138.9), indicating a neutral to mildly bullish bias. The RSI sits at 43, suggesting room for upside, while the MACD histogram turned positive (0.43) and the MACD line crossed above its signal, a classic bullish signal. Volatility remains high at ~41% over the past 30 days, and beta is modest (≈0.67), implying the stock moves less than the market but with pronounced price swings.
Fundamentally, the company posts a solid ROE of 21% and a low dividend payout ratio (≈9.6%), supporting dividend sustainability. The trailing PE of 27.5 is slightly below the industry average of 29.6, and the forward PE of 14.9 signals strong earnings growth expectations (trailing EPS 5.75 vs forward EPS 10.64). Analyst consensus is bullish (median target DKK 185, mean target DKK 176) with an implied upside of ~11%. Recent news of a New Zealand wind order tied to green‑hydrogen services adds a positive catalyst to the growth narrative.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover with positive histogram
  • Support level at DKK 151.2 and upside potential to resistance at DKK 165.6
  • Analyst upside of ~11% despite high short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward PE of 14.9 indicating accelerating earnings
  • Strong ROE (21%) and low payout ratio supporting dividend sustainability
  • Growth catalyst from new green‑hydrogen linked wind order

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term renewable energy tailwinds and global market exposure
  • Robust balance sheet with net cash position (cash > debt)
  • Consistent dividend with low payout ratio and attractive shareholder returns

Key Metrics & Analysis

Financial Health

Revenue Growth2.10%
Profit Margin4.13%
P/E Ratio27.5
ROE21.02%
ROA2.65%
Debt/Equity86.94
P/B Ratio5.4
Op. Cash FlowDKK2.3B
Free Cash FlowDKK986.2M
Industry P/E29.6

Technical Analysis

TrendNeutral
RSI43.5
SupportDKK 151.20
ResistanceDKK 165.60
MA 20DKK 158.30
MA 50DKK 172.71
MA 200DKK 138.90
MACDBullish
VolumeStable
Fear & Greed Index80.45

Valuation

Fair ValueDKK 16.28
Target PriceDKK 176.05
Upside/Downside11.21%
GradeFair
TypeBlend
Dividend Yield0.48%

Risk Assessment

Beta0.67
Volatility40.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.